131 related articles for article (PubMed ID: 8251060)
21. Analysis of B-cell epitopes in the N-terminal region of Chi t I component III using monoclonal antibodies.
van Kampen V; Becker WM; Chen Z; Rihs HP; Mazur G; Raulf M; Liebers V; Isringhausen-Bley S; Baur X
Mol Immunol; 1994 Oct; 31(15):1133-40. PubMed ID: 7523869
[TBL] [Abstract][Full Text] [Related]
22. The antibody response to a single antigenic determinant of the tobacco mosaic virus protein: analysis using monoclonal antibodies, mutant proteins and synthetic peptides.
Morrow PR; Rennick DM; Leung CY; Benjamini E
Mol Immunol; 1984 Apr; 21(4):301-9. PubMed ID: 6203033
[TBL] [Abstract][Full Text] [Related]
23. Production of monoclonal antibodies with preselected submolecular binding specificities to protein antigenic sites: antibodies to sperm whale myoglobin sites.
Schmitz HE; Atassi H; Atassi MZ
Mol Immunol; 1983 Jul; 20(7):719-26. PubMed ID: 6193418
[TBL] [Abstract][Full Text] [Related]
24. Elucidation of discontinuous linear determinants in peptides.
Appel JR; Pinilla C; Niman H; Houghten R
J Immunol; 1990 Feb; 144(3):976-83. PubMed ID: 1688594
[TBL] [Abstract][Full Text] [Related]
25. Analysis of antibody-antigen and antibody-anti-(idiotypic antibody) cross-reactivity using synthetic peptide probes.
McInerney TL; Brown LE; Sutton VR; Jackson DC
Mol Immunol; 1994 Mar; 31(4):289-99. PubMed ID: 7511212
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of a free synthetic peptide: carrier-conjugation enhances antibody affinity for the native protein.
Mariani M; Bracci L; Presentini R; Nucci D; Neri P; Antoni G
Mol Immunol; 1987 Mar; 24(3):297-303. PubMed ID: 3614216
[TBL] [Abstract][Full Text] [Related]
27. Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.
Laisney IL; Benjamin H; Gefter M; Strosberg AD
Eur J Immunol; 1996 Jul; 26(7):1634-40. PubMed ID: 8766572
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to the free beta-subunit of human chorionic gonadotropin define three distinct antigenic domains and distinguish between intact and nicked molecules.
Bidart JM; Troalen F; Lazar V; Berger P; Marcillac I; Lhomme C; Droz JP; Bellet D
Endocrinology; 1992 Oct; 131(4):1832-40. PubMed ID: 1382962
[TBL] [Abstract][Full Text] [Related]
29. Epitope mapping of the house-dust-mite allergen Der p 2 by means of site-directed mutagenesis.
Hakkaart GA; Aalberse RC; van Ree R
Allergy; 1998 Feb; 53(2):165-72. PubMed ID: 9534915
[TBL] [Abstract][Full Text] [Related]
30. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J
Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565
[TBL] [Abstract][Full Text] [Related]
31. Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells.
Ward FJ; Khan N; Wolger LJ; Howe CA; Eivazova ER; Harper N; Muller S; Staines NA
J Autoimmun; 1998 Oct; 11(5):439-47. PubMed ID: 9802927
[TBL] [Abstract][Full Text] [Related]
32. Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies.
Welling-Wester S; Feijlbrief M; Koedijk DG; Drijfhout JW; Weijer WJ; Scheffer AJ; Welling GW
Arch Virol; 1994; 138(3-4):331-40. PubMed ID: 7527999
[TBL] [Abstract][Full Text] [Related]
33. A synthetic peptide corresponding to the phosphorylcholine (PC)-binding region of human C-reactive protein possesses the TEPC-15 myeloma PC-idiotype.
Swanson SJ; Lin BF; Mullenix MC; Mortensen RF
J Immunol; 1991 Mar; 146(5):1596-601. PubMed ID: 1704398
[TBL] [Abstract][Full Text] [Related]
34. Design of peptides with improved affinities for anti-human chorionic gonadotropin monoclonal antibodies.
van Amerongen A; Plasman HH; Kuperus D; Kremer L; Rodriguez-Frade JM; Albar JP; Llopis R; Schaaper WM; Meloen RH
Pept Res; 1994; 7(2):83-90. PubMed ID: 8012125
[TBL] [Abstract][Full Text] [Related]
35. Different functional boundaries for the major antigenic region of two cytochromes c.
Jemmerson R; Johnson JG
Proc Natl Acad Sci U S A; 1991 May; 88(10):4428-32. PubMed ID: 1852010
[TBL] [Abstract][Full Text] [Related]
36. A novel epitope (pentapeptide) in the human hemoglobin beta chain.
Endo M; Nunomura W; Takakuwa Y; Hatakeyama M; Higashi T
Hemoglobin; 1998 Jul; 22(4):321-31. PubMed ID: 9730363
[TBL] [Abstract][Full Text] [Related]
37. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
[TBL] [Abstract][Full Text] [Related]
38. Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.
Redlich PN; Hoeprich PD; Colby CB; Grossberg SE
Proc Natl Acad Sci U S A; 1991 May; 88(9):4040-4. PubMed ID: 1708891
[TBL] [Abstract][Full Text] [Related]
39. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
[TBL] [Abstract][Full Text] [Related]
40. Dual specificity of a human neutralizing monoclonal antibody, specific for the V3 loop of GP120 (HIV-1).
Laisney IL; Strosberg AD
Immunol Lett; 1999 Apr; 67(3):185-92. PubMed ID: 10369125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
